SCHEMBL2049787

SCHEMBL2049787

CNC(=O)C1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21516606 1.00
SCHEMBL10153720 0.88 HDAC3 (0.42)
SCHEMBL9442 0.86 CHRNB2 (0.42)
Hydrochloric Acid SCHEMBL4621415 0.84 CHRNB2 (0.41)
SCHEMBL22446619 0.83
SCHEMBL17559298 0.81
SCHEMBL6240462 0.80
SCHEMBL25737254 0.79 HDAC8 (0.39)
SCHEMBL2828351 0.78
SCHEMBL19550635 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119241444-A Aminopyrimidinamide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2025-01-03 CN claimed
CN-119176782-A Aminopyrimidinamide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2024-12-24 CN claimed
CN-114258318-A Aminopyrimidine amide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2022-03-29 CN claimed
US-20260109698-A1 MALT-1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2026-04-23 US disclosed
EP-4525875-A1 MACROCYCLES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Merck Sharp & Dohme LLC (US) 2025-03-26 EP disclosed
US-20250051327-A1 MALT-1 MODULATORS RECURSION PHARMACEUTICALS, INC. 2025-02-13 US disclosed
CN-119241444-A Aminopyrimidinamide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2025-01-03 CN disclosed
CN-119176782-A Aminopyrimidinamide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2024-12-24 CN disclosed
CN-114258318-B Aminopyrimidinamide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2024-09-20 CN disclosed
US-12084462-B2 Spiro bicyclic inhibitors of menin-MLL interaction JANSSEN PHARMACEUTICA NV (BE) 2024-09-10 US disclosed
WO-2024006881-A1 WEE1 DEGRADING COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2024-01-04 WO disclosed
US-20100256108-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-10-07 US disclosed
EP-2192116-A1 INDAZOLE ACRYLIC ACID AMIDE COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2010-06-02 EP disclosed
US-20100056507-A1 PHENYL DERIVATIVES AND THEIR USE AS A MEDICAMENT IPSEN PHARMA S.A.S. (FR) 2010-03-04 US disclosed
US-7629468-B2 Neuroprotectants, analgesics or anticonvulsants JANSSEN PHARMACEUTICA NV (BE) 2009-12-08 US disclosed
US-7629468-B2 Neuroprotectants, analgesics or anticonvulsants JANSSEN PHARMACEUTICA NV (BE) 2009-12-08 US disclosed
EP-1971601-B1 N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES ARRAY BIOPHARMA INC (US) 2009-10-21 EP disclosed
US-7517517-B2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-14 US disclosed
US-7517517-B2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-14 US disclosed
CN-1812981-A Heteroaryloxy nitrogenous saturated heterocyclic derivative BANYU PHARMA CO LTD (JP) 2006-08-02 CN disclosed